title: Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort.
authors.affiliation: *Clinical Department, National Institute for Infectious Diseases "Lazzaro Spallanzabi", IRCCS, Rome, Italy †Department of Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy ‡Division of Infectious Diseases, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy §Division of Infectious Diseases, Department of Internal Medicine, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy ‖Division of Infectious Diseases, "Careggi" Hospital, Florence, Italy ¶Division of Infectious Diseases and Dermatology, San Gallicano Institute, IRCCS, Rome, Italy.
authors.forename: Carmela
authors.initials: C
authors.lastname: Pinnetti
authors.forename: Simona
authors.initials: S
authors.lastname: Di Giambenedetto
authors.forename: Franco
authors.initials: F
authors.lastname: Maggiolo
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Fabbiani
authors.forename: Gaetana
authors.initials: G
authors.lastname: Sterrantino
authors.forename: Alessandra
authors.initials: A
authors.lastname: Latini
authors.forename: Patrizia
authors.initials: P
authors.lastname: Lorenzini
authors.forename: Adriana
authors.initials: A
authors.lastname: Ammassari
authors.forename: Laura
authors.initials: L
authors.lastname: Loiacono
authors.forename: Rita
authors.initials: R
authors.lastname: Bellagamba
authors.forename: Evangelo
authors.initials: E
authors.lastname: Boumis
authors.forename: Roberto
authors.initials: R
authors.lastname: Cauda
authors.forename: Andrea
authors.initials: A
authors.lastname: Antinori
authors.forename: Mauro
authors.initials: M
authors.lastname: Zaccarelli
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects; D015331:Cohort Studies; D000068678:Emtricitabine, Rilpivirine, Tenofovir Drug Combination / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D000068678:Emtricitabine, Rilpivirine, Tenofovir Drug Combination; D012367:RNA, Viral